Principal Investigator
Henry Moore
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230727
Clinical Trial Summary
A Randomized, Double-blind, Placebo-controlled Study to
Evaluate the Effects of SAGE-718 on Parkinson’s Disease
Cognitive Impairment
Phase
TBD
Funding Agency/Sponsor
Other
Disease
Other
Contact Information
Study Contact
Wilfredo Rodriguez Somoza
Phone Number
+1 (561) 9394169
Email
wxr205@miami.edu